John Dixon
University of Illinois Professor Aleksei Aksimentiev is photographed next to a computer cluster used to run part of his lab's simulations involving a potentially faster and less expensive way to sequence DNA.
Sequencing a genome is still laborious and expensive, the kind of thing you do for the human race but not for a human – not routinely anyway.
Push down the price to $1,000 or less, a target at which many scientists and technologists are aiming, and testing for errors in an individual's genetic code, which may be at the root of a variety of illnesses, could become a common diagnostic procedure.
The full story is available in our paid story archive.